These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36986712)

  • 1. Self-Assembled Lecithin-Chitosan Nanoparticles Improved Rotigotine Nose-to-Brain Delivery and Brain Targeting Efficiency.
    Saha P; Singh P; Kathuria H; Chitkara D; Pandey MM
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of thermo-responsive nasal in situ gelling system dispersed with piribedil loaded lecithin-chitosan hybrid nanoparticles for improved brain availability.
    Uppuluri CT; Ravi PR; Dalvi AV
    Neuropharmacology; 2021 Dec; 201():108832. PubMed ID: 34627852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease.
    Bhattamisra SK; Shak AT; Xi LW; Safian NH; Choudhury H; Lim WM; Shahzad N; Alhakamy NA; Anwer MK; Radhakrishnan AK; Md S
    Int J Pharm; 2020 Apr; 579():119148. PubMed ID: 32084576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new fluorescence-based method for rapid and specific quantification of rotigotine in chitosan nanoparticles.
    Saha P; Pandey MM
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Feb; 267(Pt 2):120555. PubMed ID: 34749255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide.
    Al-Zuhairy SAS; Teaima MH; Shoman NA; Elasaly M; El-Nabarawi MA; El-Sawy HS
    Drug Deliv; 2023 Dec; 30(1):2189112. PubMed ID: 36916128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication, Optimization, and Evaluation of Rotigotine-Loaded Chitosan Nanoparticles for Nose-To-Brain Delivery.
    Tzeyung AS; Md S; Bhattamisra SK; Madheswaran T; Alhakamy NA; Aldawsari HM; Radhakrishnan AK
    Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30634665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, optimization and pharmacokinetic evaluation of Piribedil loaded solid lipid nanoparticles dispersed in nasal in situ gelling system for effective management of Parkinson's disease.
    Uppuluri CT; Ravi PR; Dalvi AV
    Int J Pharm; 2021 Sep; 606():120881. PubMed ID: 34273426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain targeting of agomelatine egg lecithin based chitosan coated nanoemulsion.
    Shukr MH; Farid OAA
    Pharm Dev Technol; 2021 Apr; 26(4):464-475. PubMed ID: 33586593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment.
    Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y
    Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects.
    Yan X; Xu L; Bi C; Duan D; Chu L; Yu X; Wu Z; Wang A; Sun K
    Int J Nanomedicine; 2018; 13():273-281. PubMed ID: 29391788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailoring Midazolam-Loaded Chitosan Nanoparticulate Formulation for Enhanced Brain Delivery via Intranasal Route.
    Shrestha N; Khan S; Neupane YR; Dang S; Md S; Fahmy UA; Kotta S; Alhakamy NA; Baboota S; Ali J
    Polymers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Curr Drug Discov Technol; 2019; 16(4):417-425. PubMed ID: 29669501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics.
    Fatouh AM; Elshafeey AH; Abdelbary A
    Drug Des Devel Ther; 2017; 11():1815-1825. PubMed ID: 28684900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity.
    Raj R; Wairkar S; Sridhar V; Gaud R
    Int J Biol Macromol; 2018 Apr; 109():27-35. PubMed ID: 29247729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats.
    Pailla SR; Talluri S; Rangaraj N; Ramavath R; Challa VS; Doijad N; Sampathi S
    Daru; 2019 Dec; 27(2):541-556. PubMed ID: 31256410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
    Shah B; Khunt D; Misra M; Padh H
    Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
    Mandlik SK; Ranpise NS; Mohanty BS; Chaudhari PR
    Drug Deliv Transl Res; 2018 Jun; 8(3):797-805. PubMed ID: 29380155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Brain Targeting Potential of Zolmitriptan Mucoadhesive Nanoparticles for Intranasal Drug Delivery.
    Jha S; Mishra D
    Pharm Nanotechnol; 2022; 10(2):113-124. PubMed ID: 35240970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.